ATE258804T1 - Verfahren zur verabreichung von wachstumsfaktoren - Google Patents

Verfahren zur verabreichung von wachstumsfaktoren

Info

Publication number
ATE258804T1
ATE258804T1 AT97938406T AT97938406T ATE258804T1 AT E258804 T1 ATE258804 T1 AT E258804T1 AT 97938406 T AT97938406 T AT 97938406T AT 97938406 T AT97938406 T AT 97938406T AT E258804 T1 ATE258804 T1 AT E258804T1
Authority
AT
Austria
Prior art keywords
administration
growth factors
diffusion
enhanced
growth factor
Prior art date
Application number
AT97938406T
Other languages
English (en)
Inventor
Susan Croll-Kalish
Stefano Peter S Di
Stanley J Wiegand
Ronald M Lindsay
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Application granted granted Critical
Publication of ATE258804T1 publication Critical patent/ATE258804T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
AT97938406T 1996-10-16 1997-08-19 Verfahren zur verabreichung von wachstumsfaktoren ATE258804T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2856696P 1996-10-16 1996-10-16
PCT/US1997/014536 WO1998016242A1 (en) 1996-10-16 1997-08-19 Method of enhancing the delivery of growth factors

Publications (1)

Publication Number Publication Date
ATE258804T1 true ATE258804T1 (de) 2004-02-15

Family

ID=21844162

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97938406T ATE258804T1 (de) 1996-10-16 1997-08-19 Verfahren zur verabreichung von wachstumsfaktoren

Country Status (8)

Country Link
EP (1) EP0938333B1 (de)
JP (1) JP2001502323A (de)
AT (1) ATE258804T1 (de)
AU (1) AU733394B2 (de)
CA (1) CA2269075A1 (de)
DE (1) DE69727491T2 (de)
IL (1) IL129482A0 (de)
WO (1) WO1998016242A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002524402A (ja) * 1998-09-03 2002-08-06 ニューロンズ・リミテッド 神経保護
FR2793684B1 (fr) * 1999-05-17 2001-08-10 Ethypharm Lab Prod Ethiques Utilisation de microspheres biodegradables liberant un agent anticancereux pour le traitement du glioblastome, procede de preparation de ces microspheres et suspension les contenant
US7112570B2 (en) 2000-08-24 2006-09-26 Neuren Pharmaceuticals, Ltd. GPE analogs
GB0303362D0 (en) * 2003-02-13 2003-03-19 Enact Pharma Plc Tissue regeneration
GB2547179A (en) * 2015-10-26 2017-08-16 Quethera Ltd Genetic construct
GB202303495D0 (en) * 2023-03-09 2023-04-26 Ucl Business Ltd Therapy for charcot-marie-tooth disease

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8804164A0 (sv) * 1988-11-17 1990-05-18 Per Prisell Farmaceutisk beredning
PT101051A (pt) * 1991-11-12 1994-02-28 Regeneron Pharma Uso de nt-3, de anticorpo neutralizante anti-nt-3 e de molecula de ribozima ou anti-sentido no fabrico de um medicamento para o tratamento de desordens do sistema nervoso e processo de analise relacionados com nt-3
WO1994021282A1 (en) * 1993-03-19 1994-09-29 Immunex Corporation Pharmaceutical compositions comprising a ligand complexed with a soluble receptor

Also Published As

Publication number Publication date
AU4073797A (en) 1998-05-11
AU733394B2 (en) 2001-05-10
EP0938333A1 (de) 1999-09-01
IL129482A0 (en) 2000-02-29
DE69727491D1 (de) 2004-03-11
CA2269075A1 (en) 1998-04-23
WO1998016242A1 (en) 1998-04-23
EP0938333B1 (de) 2004-02-04
DE69727491T2 (de) 2004-12-02
JP2001502323A (ja) 2001-02-20

Similar Documents

Publication Publication Date Title
EA200000445A1 (ru) Способы лечения состояния гиперкоагуляции или приобретенной недостаточности белка c
DE69326125D1 (de) System zur Anwendung von Knoten in chirurgischem Nahtmaterial
DE69631157D1 (de) Pharmazeutische Zubereitung zur Verwendung in der Behandlung von Diabetes
FI900888A7 (fi) Menetelmä ja laite tasavirtapulssien ohjatuksi, paikalliseksi syöttämiseksi ihmisen ja eläimen kudoksiin
ZA975851B (en) Hepatocyte grown factor receptor agonists and uses thereof
DE69027865D1 (de) ZUSAMMENSETZUNGEN enthaltend omega Conotoxin Peptide Derivate und deren Verwendung ZUR BEHANDLUNG VON ISCHÄMIE-ARTIGEN NEURONALEN SCHÄDIGUNGEN
DE69710095D1 (de) Pharmazeutische zubereitung zur behandlung von diabetes
BR9801355B1 (pt) emulsço àleo-em-Água, composiÇço cosmÉtica de uso tàpico, utilizaÇço de uma emulsço, processo de tratamento nço terapÊutico da pele e processo de preparaÇço de uma emulsço.
EE9700225A (et) Meetod diabetes mellituse raviks, kasutades KKF
EP1264604A3 (de) Verbesserungen in oder an Kontrastmitteln
FI951468L (fi) Lipopeptidijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö
ATE135216T1 (de) Verwendung von spiperone-derivate zur immunosuppression
ATE181422T1 (de) Verfahren zur diagnose von praeklampsie
KR960701648A (ko) Pdgf와 비타민 d를 함유하는 조골세포 성장 자극 조성물(oesteoblast growth stimulating compostion containing pdgf and vitamind)
DE69630877D1 (de) Hapten-träger-konjugate zur anwendung in der drogen-missbrauchs-therapie
ATE183774T1 (de) Löslicher interferon-rezeptor, seine herstellung und anwendung
ATE258804T1 (de) Verfahren zur verabreichung von wachstumsfaktoren
DE3787477D1 (de) Nasal applizierbares Arzneimittel, Verfahren zu seiner Herstellung und seine Verwendung.
DE69133140D1 (de) 2-Aryl-5-(trifluoromethyl)-2-pyrrolinderivate und Verfahren zur Herstellung von 2-Aryl-1-(alkoxymethyl)-4-halo-5-(trifluoromethyl)-pyrrolen mit insektizider Wirkung
DE59611383D1 (de) Darreichungsform zur applikation von pharmazeutischen wirkstoffen und hilfsstoffen und verfahren zur herstellung derselben
DE3677910D1 (de) Haarwuchspraeparat das vasoaktives darmpolypeptid als aktives mittel enthaelt und verfahren zur anwendung dieses praeparats zum foerdern des haarwuchses.
DE69734349D1 (de) Behandlung von knochenleiden mit adrenomedullin
KR900017599A (ko) 종양 치료용 약학 조성물
NO985260D0 (no) In vivo fargingsblanding, fremgangsmÕte for fremstilling og metode for anvendelse for Õ identifisere dysplastisk vev
PL332035A1 (en) Transdermal therapeutic system including an estriol-containing composition of active substances

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0938333

Country of ref document: EP